M67.21
Synovial hypertrophy, not elsewhere classified, shoulder
Clinical Classification Guidelines
Medical Intelligence & Overview
Synovial hypertrophy of the shoulder, classified under ICD-10 code M67.21, is a condition characterized by thickening of the synovial membrane within the shoulder joint. The synovium is a thin layer of tissue that lines the joint capsule, producing synovial fluid which lubricates and nourishes the cartilage. When this tissue becomes abnormally thickened, it can lead to discomfort, restricted movement, and joint dysfunction. Although this condition is not widely discussed, understanding its causes, symptoms, and available treatment options can be helpful for those affected.
Causes & Symptoms
Clinical Causes: Chronic inflammation due to conditions like rheumatoid arthritis Repetitive shoulder injuries or overuse Degenerative joint diseases such as osteoarthritis Infections affecting the shoulder joint Previous shoulder trauma or surgery Autoimmune disorders leading to joint inflammation
Key Symptoms: Persistent shoulder pain, especially during movement Swelling or palpable thickening around the shoulder Limited range of motion and stiffness A sensation of catching or locking in the shoulder joint Weakness in shoulder movements Discomfort that worsens with activity or over time
Diagnostic & Treatment
Diagnosis Path: Diagnosing synovial hypertrophy involves a combination of clinical evaluation and imaging studies. A healthcare professional may conduct a physical examination to assess range of motion, tenderness, and swelling. Advanced imaging techniques such as magnetic resonance imaging (MRI) or ultrasound are valuable in visualizing the thickened synovial tissue, distinguishing it from other joint issues, and confirming the diagnosis. Sometimes, joint aspiration may be performed to analyze synovial fluid for signs of inflammation or infection.
Treatment Protocols: Treatment strategies aim to reduce inflammation, relieve pain, and restore shoulder function. Common approaches include: - **Medications:** Nonsteroidal anti-inflammatory drugs (NSAIDs) to diminish swelling and pain; corticosteroid injections for targeted relief. - **Physical therapy:** Customized exercises designed to improve strength, flexibility, and joint mobility. - **Lifestyle modifications:** Resting the shoulder, avoiding activities that aggravate symptoms, and ergonomic adjustments. - **Surgical options:** In cases where conservative therapies do not provide relief, procedures like synovectomy (removal of the hypertrophied synovial tissue) may be performed to alleviate symptoms and improve joint function. It is important to consult with healthcare professionals for personalized management plans suited to individual conditions.
Clinical Advice & FAQs
Billing Guidance
Is M67.21 a billable ICD-10 code?
Yes, M67.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M67.21?
Clinical documentation must specify the nature of Synovial hypertrophy, not elsewhere classified, shoulder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference